Trabectedin Dealers in Katargam, Surat

We make available the product range that is as per the customers; exact requirement and needs. Being a quality driven firm, we source the raw material from the certified vendors only who assure us for the quality and reliability of the material.

• Product Name: Bortezomib
• Grade: IP / BP / USP
• Therapeutic Category: Antineoplastic
• CAS No: 179324-69-7
• M.F.: C19H25BN4O4
• M.W.: 384.2372
• Appearance: white or almost white powder
• Usage: to treat multiple myeloma
• Packaging: 25kg/drum
• Storage: Stored in a clean, cool, dry area

• Packaging Size: 1 Injection in 1 Vial
• Brand Name: Bortenat
• Manufacturer: Natco Pharma Ltd
• Packaging Type: Vial
• Shelf Life: 24 months
• Composition: Bortezomib
• Treatment: Multiple Myeloma and Mantle-cell Lymphoma
• Prescription/Non prescription: Prescription
• Dosage Form: Injection
• Strength: 2mg or 3.5mg

• PANTRONI I.V.: Pantoprazole I.V. 40 mg.

• orally: treatment of uncomplicated falciparum malaria in areas where there is evidence of chloroquine, pyrimethaminesulfadoxine, mefloquine and quinine resistance. It should always be administered together with mefloquine in full therapeutic dose. • parenterally: treatment of severe falciparum malaria in areas where there is evidence of quinine resistance. Radical cure is then effected with a full course of an effective oral antimalarial. Product details: minimum order quantity 100 unit product type finished product usage clinical, hospital

• Country of Origin: Made in India
• Shelf Life: 3 YEARS
• Form: Injection
• Packaging Type: Vial
• Brand Name: Bortenat
• Manufactured By: NATCO
• Prescription/Non prescription: Prescription
• Composition: Bortezomib

• Form: Injection
• Brand Name: Natco
• Strength :-: 100 Mg
• Country of Origin: India
• Type: Bottle
• Material (composition): Bendamustine hydrochloride
• usage: hospital

Bendamustine an anti cancer drug is prescribed for the treatment of chronic lymphocytic leukaemia The drug is prescribed or the treatment of indolent B-cell non-hodgkin’s lymphoma that is drug-resistant to other therapies